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To the Editor: In the August issue of this journal, the
European Paediatric Research Group for hemolytic uremic
syndrome (HUS), proposed a new etiology-based classifica-
tion of HUS/thrombotic thrombocytopenic purpura (HUS/
TTP).1 According to them, two groups can be defined: the
first with etiologies well elucidated, and the second present-
ing only clinical associations with incriminated agents. Shiga
toxin-producing bacteria, including Escherechia coli, are listed
as a major player in the first group. As regards E. coli, the
authors focussed their discussion exclusively on the ‘classical’
clinical presentation of diarrhea-associated HUS. Surpris-
ingly, no mention is made of HUS induced by Shiga toxin-
producing E. coli associated with urinary tract infections
(UTIs). Indeed, 18 such cases have been reported so far,2,3
and we have recently treated another patient with full-blown
HUS complicating a urosepsis.
We suggest UTI-associated HUS be included in the
classification for the following reasons: firstly, unawareness
of this clinical presentation may retard its diagnosis, set off
unnecessary research for a wide range of other rare etiologies
of HUS, lead to unjudicious therapeutic choices, and
ultimately affect patients’ outcome.
Second, with E. coli being the leading cause of UTI, the
extremely low incidence of UTI-associated HUS is in fact
surprising. One partial explanation was given by Johnson
et al.,4 who had found no single Shiga toxin-producing E. coli
among 597 E. coli isolates from a wide range of UTIs.4
Whether uropathogen strains are protected against Shiga
toxin genes harboring bacteriophages is another interesting
question which can be addressed by current microbiological
techniques.
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Members of the European Paediatric Study Group1 for
hemolytic uremic syndrome are aware of cases of
hemolytic uremic syndrome in which verocytotoxin
(shiga-like toxin)-producing Escherichia coli infects the
urinary tract and apparently not the intestine. In these
cases, the etiology seems reasonably advanced and it would
be appropriate for them to be classified in our proposal
under Part 1, ‘Ia, Shiga and verocytotoxin (shiga-like
toxin)-producing bacteria’. The fact that we did not
mention the phenomenon of primary verocytotoxin
(shiga-like toxin)-producing E. coli urinary infection
reflects both the shortage of space in a review article and
the rarity of the occurrence. In the investigative guideline
that we referred, http://espn.uwcm.ac.uk/guidelines.htm
we point out that a causative verocytotoxin (shiga-like
toxin)-producing E. coli infection may not induce diarrhea.
We assume that evidence of urinary infection is sought
routinely in all cases of acute renal failure and agree that if
E. coli or possibly other Gram-negative organisms are
identified in a patient with hemolytic uremic syndrome,
they should be investigated for the ability to produce
verocytotoxins.
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